Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Apr 28;9(5):22.
doi: 10.1167/tvst.9.5.22. eCollection 2020 Apr.

Histologic Changes Following Continuous Wave and Micropulse Transscleral Cyclophotocoagulation: A Randomized Comparative Study

Affiliations
Randomized Controlled Trial

Histologic Changes Following Continuous Wave and Micropulse Transscleral Cyclophotocoagulation: A Randomized Comparative Study

Kareem Moussa et al. Transl Vis Sci Technol. .

Abstract

Purpose: To compare the macroscopic and microscopic histologic changes in eyes treated with micropulse transscleral cyclophotocoagulation (MP-TCP) versus continuous wave transscleral cyclophotocoagulation (CW-TCP).

Methods: Twelve halves of globes from three pairs of adult cadaveric eyes were randomly assigned to nontreated control, CW-TCP, single MP-TCP treatment, or double MP-TCP treatments, and then sectioned for histologic analysis. Presence or absence of the following four unique histologic changes was recorded: splitting within the ciliary process epithelium (splitting), separation of the pigmented ciliary process epithelium from the stroma (separation), coagulation of collagen and destruction of ciliary process stroma (coagulation), and full-thickness destruction of ciliary process epithelium (destruction).

Results: A total of 498 slides were analyzed, and laser scars in all treated specimens were located in the pars plana. Logistic regression analysis showed that compared with controls, CW-TCP-treated specimens were significantly more likely to experience separation (odds ratio [OR] = 11.1, P = 0.02), coagulation (OR = 24.3, P = 0.002), and destruction (OR = 11.1, P = 0.03). Destruction of the ciliary process epithelium was observed exclusively in CW-TCP-treated sections. No significant differences in histologic features were observed between controls and MP-TCP.

Conclusions: MP-TCP does not produce significant histologic changes in cadaveric eyes, whereas CW-TCP treatment does.

Translational relevance: These findings improve understanding of the mechanism of MP-TCP, help explain the increased rates of adverse effects following CW-TCP treatment compared with MP-TCP, and describe effects of MP-TCP at various doses.

Keywords: CW-TCP; MP-TCP; cyclophotocoagulation; histology.

PubMed Disclaimer

Conflict of interest statement

Disclosure: K. Moussa, None; M. Feinstein, None; M. Pekmezci, None; J.H. Lee, None; M. Bloomer, None; C. Oldenburg, None; Z. Sun, None; R.K. Lee, None; G.-S. Ying, None; Y. Han, None

Figures

Figure 1.
Figure 1.
Diagrammatic representation of processing of tissue specimens.
Figure 2.
Figure 2.
Representative images depicting histologic features included in the study. Hematoxylin and stained sections, 100x magnification. Green asterisk: splitting within the ciliary epithelium, between pigmented and nonpigmented epithelia; blue arrowhead: separation of the pigmented ciliary epithelium from the stroma; red arrowhead: coagulation of collagen and destruction of ciliary body stroma; green diamond: full-thickness destruction of ciliary epithelium. (A) Control, (B) double MP-TCP-treated eye, (C-D) CW-TCP-treated eyes.
Figure 3.
Figure 3.
Macroscopic changes following continuous wave and MP-TCP treatment in adult cadaveric eyes. The laser burns (blue arrow) are seen exclusively within the pars plana. Adult eye treated with CW-TCP (A and C). Adult eye treated with MP-TCP (B and D). Note the grossly evident tissue rupture in (C).
Figure 4.
Figure 4.
Percentage of sections demonstrating each histologic feature by treatment group. ***Indicates P < 0.001.

References

    1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90: 262–267. - PMC - PubMed
    1. Kass MA, Heuer DK, Higginbotham EJ, et al. .. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol Chic Ill 1960. 2002; 120: 701–713; discussion 829–830. - PubMed
    1. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998; 126: 487–497. - PubMed
    1. Blasini M, Simmons R, Shields MB. Early tissue response to transscleral neodymium: YAG cyclophotocoagulation. Invest Ophthalmol Vis Sci. 1990; 31: 1114–1118. - PubMed
    1. Murphy CC, Burnett CaM, Spry PGD, Broadway DC, Diamond JP. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2003; 87: 1252–1257. - PMC - PubMed

Publication types